Open Access
Table II.
Statistical comparisons between mRNA levels of expression. Levels of expression are shown in the second column (High: Amplification around 17–24 cycle thresholds (Ct), very low more than 33 Ct). When the data were paired and normally distributed, group means were compared using Student’s Paired t-test. Paired, non-normally distributed data were analysed using the Wilcoxon Signed Rank Test (Exact).
Messenger RNA | Level of expression |
P value |
||
---|---|---|---|---|
cPP vs. iPP | cGW vs. iGW | cPP vs. cGW | ||
APRIL/TNFSF13 | High | 0.096 > | 0.127 | 0.069 < |
BAFF/TNFSF13B | High | 0.006 ** < | 0.058 < | 0.009 ** > |
CCL20/MIP3 alpha | High | 0.368 | 0.288 | 0.510 |
CCL25/TECK | High | 0.008 ** > | 0.009 ** > | 0.121 |
CCL28/MEC | Moderate | 0.381 | 0.114 | 0.027 * < |
CCR9 | High | 0.004 ** > | 0.559 | 0.227 |
CCR10 | Moderate | 0.433 | 0.213 | 0.148 |
CCRL1/CCR11 | High | 0.059 > | 0.318 | 0.573 |
CD40L | Moderate | 0.128 | 0.382 | 0.004 ** > |
CX3CL1/Fractalkine | Moderate | 0.1727 | 0.007 ** < | 0.083 > |
CX3CR1 | Low | 0.671 | 0.236 | 0.103 |
CXCL2/GRO beta | Moderate | 0.117 | 0.013 * < | 0.637 |
CXCL10/IP-10 | High | 0.002 ** < | 0.010 ** < | 0.565 |
FOXP3 | Low | 0.609 | 0.305 | 0.001 ** > |
GATA3 | Low | 0.220 | 0.399 | 0.048 * > |
GM-CSF/CSF-2 | Low | 0.452 | 0.156 | 0.227 |
IL2/TCGF | Low | 0.201 | 0.608 | 0.038 * > |
IL1 beta/LAF | Very low | na | na | na |
IL4/BCGF | Very low | 0.616 | 0.061 < | 0.383 |
IL5/EDF | Moderate | 0.086 > | 0.375 | 0.639 |
IL6/IFN beta 2 | Moderate | 0.013 * < | 0.039 * < | 0.592 |
IL8/CXCL-8 | High | 0.149 | 0.001 ** < | 0.843 |
IL10/B-TCGF | Moderate | 0.118 | 0.067 * < | 0.806 |
IL12 p35 | Moderate | 0.009 ** < | 0.001 ** < | 0.003 ** > |
IL12 p40 | Moderate | 0.003 ** < | 0.027 * < | 0.018 * > |
IL13 | Very low | 0.151 | 0.091 < | 0.415 |
IL15/IL-T | Moderate | 0.263 | 0.142 | 0.813 |
IL17a/CTLA8 | Low | 0.541 | 0.062 < | 0.239 |
IL18/IGIF | High | 0.150 | 0.869 | 0.187 |
IL21 | Low | 0.319 | 0.553 | 0.238 |
IL22/IL-TIF | Moderate | 0.100 | 0.761 | 0.684 |
IL23 p19 | Moderate | 0.325 | 0.922 | 0.036 * < |
IL27 p28 | Moderate | 0.019 * < | 0.105 | 0.239 |
IL33 | Moderate | 0.022 * < | 0.703 | 0.322 |
IFN gamma | Moderate | 0.010 * < | 0.009 ** < | 0.237 |
iNOS | Moderate | 0.009 ** < | 0.015 * < | 0.831 |
LTA/TNF beta | Low | 0.972 | 0.715 | 0.141 |
MAdCAM-1 | High | 0.244 | 0.148 | 0.410 |
NK-lysin | High | 0.164 | 0.354 | 0.181 |
NOD2 | Moderate | 0.013 * < | 0.004 ** < | 0.102 |
PBD-1 | Moderate | 0.213 | 0.051 > | 0.065 > |
PBD-2 | Moderate | 0.017 * < | 0.280 | 0.025 * < |
PMAP-37/cathelicidin | Very low | 0.013 < < | 0.289 | 0.134 |
PR-39 | Very low | 0.106 | 0.089 > | 0.027 * > |
RORC/ROR gamma | Moderate | 0.340 | 0.201 | 0.035 * < |
Secretory component | High | 0.026 * > | 0.037 * > | 0.122 |
SMAD2 | High | 0.648 | 0.613 | 0.052 > |
SMAD3 | Moderate | 0.070 > | 0.849 | 0.644 |
STAT3 | High | 0.606 | 0.224 | 0.856 |
STAT4 | Moderate | 0.363 | 0.015 * < | 0.018 * > |
STAT5 | Moderate | 0.828 | 0.846 | 0.629 |
STAT6 | Moderate | 0.828 | 0.691 | 0.155 |
T-Bet | Low | 0.710 | 0.207 | 0.127 |
TGF beta | Moderate | 0.253 | 0.002 ** < | 0.005 ** > |
TLR2 | Moderate | 0.002 ** < | 0.044 * < | 0.797 |
TLR4 | Moderate | 0.001 ** < | 0.020 * < | 0.021 * > |
TLR5 | Moderate | 0.020 * > | 0.001 ** > | 0.514 |
TNF alpha/TNFSF2 | Moderate | 0.007 ** < | 0.002 ** < | 0.004 ** > |